Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Biotech
FDA's Richard Pazdur explains confirmatory trial rejection, more
The FDA's oncology chief also challenged biopharma companies to discuss more simplified trial designs with the agency under Project Pragmatica.
Angus Liu
Apr 8, 2024 6:00am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
'The Top Line': Unraveling Alzheimer's disease treatments
Oct 13, 2023 6:00am
Panel of FDA experts endorses Pfizer's RSV vaccine prospect
Feb 28, 2023 4:59pm
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
Follow-up trials should be underway for accelerated nods: Pazdur
Nov 17, 2022 3:36pm